Literature DB >> 25577170

Atorvastatin Protects NSC-34 Motor Neurons Against Oxidative Stress by Activating PI3K, ERK and Free Radical Scavenging.

Seok-Ho Lee1, Na-Young Choi2, Hyun-Jeung Yu3, Jinse Park4, Hojin Choi1, Kyu-Yong Lee1, Yong-Min Huh5, Young Joo Lee6, Seong-Ho Koh7,8.   

Abstract

Although statins, or hydroxymethylglutaryl coenzyme A (HMG-Co A) reductase inhibitors, are generally used to decrease levels of circulating cholesterol, they have also been reported to have neuroprotective effects through various mechanisms. However, recent results have indicated that they may be harmful in patients with amyotrophic lateral sclerosis (ALS). In this study, we investigate whether atorvastatin protects motor neuron-like cells (NSC-34D) from oxidative stress. To evaluate the effects of atorvastatin or hydrogen peroxide or both on NSC-34D cells, the cells were treated with various combinations of these agents. To evaluate the viability of the cells, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays and trypan blue staining were performed. Levels of free radicals and intracellular signaling proteins were evaluated using the fluorescent probe 2',7'-dichlorodihydrofluorescein diacetate (DCFH-DA) and Western blotting, respectively. Atorvastatin protected NSC-34D cells against oxidative stress in a concentration-dependent manner. This neuroprotective effect of atorvastatin was blocked by LY294002, a phosphatidylinositol 3-kinase (PI3K) inhibitor and by FR180204, a selective extracellular signal-related kinase (ERK) inhibitor. Atorvastatin treatment increased the expression levels of p85αPI3K, phosphorylated Akt, phosphorylated glycogen synthase kinase-3β, phosphorylated ERK, and Bcl-2, which are proteins related to survival. Furthermore, atorvastatin decreased the levels of cytosolic cytochrome C, Bax, cleaved caspase-9, and cleaved caspase-3, which are associated with death in oxidative stress-injured NSC-34D cells. We conclude that atorvastatin has a protective effect against oxidative stress in motor neurons by activating the PI3K and ERK pathways as well as by scavenging free radicals. These findings indicate that statins could help protect motor neurons from oxidative stress.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Extracellular signal-related kinase; Phosphatidylinositol 3-kinase; Statin

Mesh:

Substances:

Year:  2015        PMID: 25577170     DOI: 10.1007/s12035-014-9030-0

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  43 in total

Review 1.  Impact of HMG-CoA reductase inhibition on brain pathology.

Authors:  Frauke Zipp; Sonia Waiczies; Orhan Aktas; Oliver Neuhaus; Bernhard Hemmer; Burkhard Schraven; Robert Nitsch; Hans-Peter Hartung
Journal:  Trends Pharmacol Sci       Date:  2007-06-15       Impact factor: 14.819

Review 2.  Statins: drugs for Alzheimer's disease?

Authors:  G P Eckert; W G Wood; W E Müller
Journal:  J Neural Transm (Vienna)       Date:  2005-01-31       Impact factor: 3.575

Review 3.  Hydrogen peroxide: a signaling messenger.

Authors:  James R Stone; Suping Yang
Journal:  Antioxid Redox Signal       Date:  2006 Mar-Apr       Impact factor: 8.401

4.  Bcl-2 upregulation and neuroprotection in guinea pig brain following chronic simvastatin treatment.

Authors:  Cornelia Franke; Michael Nöldner; Reham Abdel-Kader; Leslie N Johnson-Anuna; W Gibson Wood; Walter E Müller; Gunter P Eckert
Journal:  Neurobiol Dis       Date:  2006-12-06       Impact factor: 5.996

Review 5.  Oxidative stress and motor neurone disease.

Authors:  M R Cookson; P J Shaw
Journal:  Brain Pathol       Date:  1999-01       Impact factor: 6.508

6.  An evaluation of a data mining signal for amyotrophic lateral sclerosis and statins detected in FDA's spontaneous adverse event reporting system.

Authors:  Eric Colman; Ana Szarfman; Jo Wyeth; Andrew Mosholder; Devanand Jillapalli; Jonathan Levine; Mark Avigan
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-11       Impact factor: 2.890

7.  Are statin medications safe in patients with ALS?

Authors:  Lorne Zinman; Reza Sadeghi; Marek Gawel; Dan Patton; Alex Kiss
Journal:  Amyotroph Lateral Scler       Date:  2008-08

8.  Role of the phosphatidylinositol 3-kinase and extracellular signal-regulated kinase pathways in the neuroprotective effects of cilnidipine against hypoxia in a primary culture of cortical neurons.

Authors:  Sangjae Kim; Kyu-Yong Lee; Seong-Ho Koh; Hyun-Hee Park; Hyun-Jeung Yu; Young Joo Lee
Journal:  Neurochem Int       Date:  2012-08-24       Impact factor: 3.921

9.  Statin use and the risk of Parkinson disease.

Authors:  Angelika D Wahner; Jeff M Bronstein; Yvette M Bordelon; Beate Ritz
Journal:  Neurology       Date:  2008-01-09       Impact factor: 9.910

10.  Simvastatin inhibits cancer cell growth by inducing apoptosis correlated to activation of Bax and down-regulation of BCL-2 gene expression.

Authors:  Carmine Spampanato; Salvatore De Maria; Maddalena Sarnataro; Elisabetta Giordano; Mario Zanfardino; Salvatore Baiano; Maridela Cartenì; Franco Morelli
Journal:  Int J Oncol       Date:  2011-11-29       Impact factor: 5.650

View more
  9 in total

1.  Atorvastatin Prevents Glutamate Uptake Reduction Induced by Quinolinic Acid Via MAPKs Signaling.

Authors:  S Vandresen-Filho; W C Martins; D B Bertoldo; D K Rieger; M Maestri; R B Leal; C I Tasca
Journal:  Neurochem Res       Date:  2016-04-15       Impact factor: 3.996

2.  Identification of an individual with a SYGNAP1 pathogenic mutation in India.

Authors:  Vijaya Verma; Amit Mandora; Abhijeet Botre; James P Clement
Journal:  Mol Biol Rep       Date:  2020-10-22       Impact factor: 2.316

3.  Selected gene profiles of stressed NSC-34 cells and rat spinal cord following peripheral nerve reconstruction and minocycline treatment.

Authors:  Gerburg Keilhoff; Benjamin Lucas; Katja Uhde; Hisham Fansa
Journal:  Exp Ther Med       Date:  2016-03-02       Impact factor: 2.447

4.  Highly Efficient Conversion of Motor Neuron-Like NSC-34 Cells into Functional Motor Neurons by Prostaglandin E2.

Authors:  Hiroshi Nango; Yasuhiro Kosuge; Masaki Sato; Yoshiyuki Shibukawa; Yuri Aono; Tadashi Saigusa; Yoshihisa Ito; Kumiko Ishige
Journal:  Cells       Date:  2020-07-21       Impact factor: 6.600

5.  The protective effect of non-invasive low intensity pulsed electric field and fucoidan in preventing oxidative stress-induced motor neuron death via ROCK/Akt pathway.

Authors:  Chih-Hsiung Hsieh; Chueh-Hsuan Lu; Yu-Yi Kuo; Guan-Bo Lin; Chih-Yu Chao
Journal:  PLoS One       Date:  2019-03-19       Impact factor: 3.240

6.  Histaminergic transmission slows progression of amyotrophic lateral sclerosis.

Authors:  Savina Apolloni; Susanna Amadio; Paola Fabbrizio; Giovanna Morello; Antonio Gianmaria Spampinato; Emanuele Claudio Latagliata; Illari Salvatori; Daisy Proietti; Alberto Ferri; Luca Madaro; Stefano Puglisi-Allegra; Sebastiano Cavallaro; Cinzia Volonté
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-04-24       Impact factor: 12.910

7.  Tat-protein disulfide-isomerase A3: a possible candidate for preventing ischemic damage in the spinal cord.

Authors:  Dae Young Yoo; Su Bin Cho; Hyo Young Jung; Woosuk Kim; Goang-Min Choi; Moo-Ho Won; Dae Won Kim; In Koo Hwang; Soo Young Choi; Seung Myung Moon
Journal:  Cell Death Dis       Date:  2017-10-05       Impact factor: 8.469

8.  Comprehensive evaluation of effects and safety of statin on the progression of liver cirrhosis: a systematic review and meta-analysis.

Authors:  Yue Gu; Xueqin Yang; Hang Liang; Deli Li
Journal:  BMC Gastroenterol       Date:  2019-12-30       Impact factor: 3.067

9.  Statin therapy in chronic viral hepatitis: a systematic review and meta-analysis of nine studies with 195,602 participants.

Authors:  Amir Vahedian-Azimi; Sajad Shojaie; Maciej Banach; Farshad Heidari; Arrigo F G Cicero; Masoum Khoshfetrat; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.